国立医薬品食品衛生研究所

研究業績

論文

2014

  1. Ohoka, N., Nagai, K., Hattori, T., Okuhira, K., Shibata, N., Cho, N. and Naito, M: Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin proteasome pathway. Cell Death Dis. 2014;5:e1513.
  2. Nagakubo, T., Demizu, Y., Kanda, Y., Misawa, T., Shoda, T., Okuhira, K., Sekino., Y., Naito, M. and Kurihara, M: Development of cell-penetrating R7 fragment-conjugated helical peptides as inhibitors of estrogen receptor-mediated transcription. Bioconjug Chem. 2014;25:1921-24.
  3. Cui, H., Wu, W., Okuhira, K., Miyazawa, K., Hattori, T., Sai, K., Naito, M., Suzuki, K., Nishimura, T., Sakamoto, Y., Ogata, A., Maeno, T., Inomata, A., Nakae, D., Hirose, A. and Nishimaki-Mogami, T: High-temperature calcined fullerene nanowhiskers as well as long needle-like multi-wall carbon nanotubes have abilities to induce NLRP3-mediated IL-1β secretion. Biochem Biophys Res Commun. 2014;452:593-99.
  4. Hashimoto, Y., Takeshita, Y., Naito, M., Uchino, H. and Matsuoka, M: Apollon/Bruce is upregulated by Humanin. Mol Cell Biochem. 2014; 397:147-55.
  5. Shoda, T., Okuhira, K., Kato, M., Demizu, Y., Inoue, H., Naito, M. and Kurihara, M.: Design and synthesis of tamoxifen derivatives as a selective estrogen receptor down-regulator. Bioorg Med Chem Lett. 2014;24:87-9.
  6. Kikuchi, R., Ohata, H., Ohoka, N., Kawabata, A. and Naito, M.: APOLLON Protein Promotes Early Mitotic CYCLIN A Degradation Independent of the Spindle Assembly Checkpoint. J Biol Chem. 2014;289:3457-67.
  7. Hattori, T., Uchida, C., Takahashi, H., Yamamoto, N., Naito, M. and Taya, Y.: Distinct and site-specific phosphorylation of the retinoblastoma protein at serine 612 in differentiated cells. PLoS one. 2014;9:e86709.
  8. 内田恵理子,古田美玲,菊池裕,窪崎敦隆,遊佐精一,宮原美知子,佐々木裕子,小原有弘,大谷梓,松山晃文,大倉華雪, 山口照英: 細胞基材に対するマイコプラズマ否定試験のPCR法の見直しに関する研究、医薬品医療機器レギュラトリーサイエンス 45 (5), 442-451 (2014)
  9. 内田恵理子、五十嵐友香、佐藤陽治:遺伝性難病に対する遺伝子治療薬の臨床開発促進のためのレギュラトリーサイエンス共同研究、衛研報告 132, 10-12(2014)

学会発表

2014

2015